139 related articles for article (PubMed ID: 12880346)
1. Application of an ex ovo chicken chorioallantoic membrane model for two-photon excitation photodynamic therapy of age-related macular degeneration.
Samkoe KS; Cramb DT
J Biomed Opt; 2003 Jul; 8(3):410-7. PubMed ID: 12880346
[TBL] [Abstract][Full Text] [Related]
2. Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration.
Samkoe KS; Clancy AA; Karotki A; Wilson BC; Cramb DT
J Biomed Opt; 2007; 12(3):034025. PubMed ID: 17614733
[TBL] [Abstract][Full Text] [Related]
3. A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV.
Lange N; Ballini JP; Wagnieres G; van den Bergh H
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):38-46. PubMed ID: 11133846
[TBL] [Abstract][Full Text] [Related]
4. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
[TBL] [Abstract][Full Text] [Related]
5. Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.
Soubrane G; Bressler NM
Br J Ophthalmol; 2001 Apr; 85(4):483-95. PubMed ID: 11264143
[No Abstract] [Full Text] [Related]
6. Vascular-targeted photodynamic therapy in the treatment of neovascular age-related macular degeneration: Clinical perspectives.
Kawczyk-Krupka A; Bugaj AM; Potempa M; Wasilewska K; Latos W; Sieroń A
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):161-75. PubMed ID: 25843911
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in Canada.
Earnshaw SR; Moride Y; Rochon S
Clin Ther; 2007 Sep; 29(9):2096-106; discussion 2094-5. PubMed ID: 18035208
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of synergistic effects of hyperthermia and photodynamic therapy using the chick chorioallantoic membrane model.
Kimel S; Svaasand LO; Hammer-Wilson M; Gottfried V; Cheng S; Svaasand E; Berns MW
Lasers Surg Med; 1992; 12(4):432-40. PubMed ID: 1379665
[TBL] [Abstract][Full Text] [Related]
9. Drug and light dose responses to focal photodynamic therapy of single blood vessels in vivo.
Khurana M; Moriyama EH; Mariampillai A; Samkoe K; Cramb D; Wilson BC
J Biomed Opt; 2009; 14(6):064006. PubMed ID: 20059244
[TBL] [Abstract][Full Text] [Related]
10. Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration.
Zuluaga MF; Mailhos C; Robinson G; Shima DT; Gurny R; Lange N
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1767-72. PubMed ID: 17389510
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
[TBL] [Abstract][Full Text] [Related]
12. Verteporfin: a milestone in opthalmology and photodynamic therapy.
Brown SB; Mellish KJ
Expert Opin Pharmacother; 2001 Feb; 2(2):351-61. PubMed ID: 11336591
[TBL] [Abstract][Full Text] [Related]
13. Systemic application of photosensitizers in the chick chorioallantoic membrane (CAM) model: photodynamic response of CAM vessels and 5-aminolevulinic acid uptake kinetics by transplantable tumors.
Hornung R; Hammer-Wilson MJ; Kimel S; Liaw LH; Tadir Y; Berns MW
J Photochem Photobiol B; 1999 Mar; 49(1):41-9. PubMed ID: 10365445
[TBL] [Abstract][Full Text] [Related]
14. The neovessel occlusion efficacy of 15-hydroxypurpurin-7-lactone dimethyl ester induced with photodynamic therapy.
Lim SH; Nowak-Sliwinska P; Kamarulzaman FA; van den Bergh H; Wagnières G; Lee HB
Photochem Photobiol; 2010; 86(2):397-402. PubMed ID: 20074086
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic parameters in the chick chorioallantoic membrane (CAM) bioassay for topically applied photosensitizers.
Hammer-Wilson MJ; Akian L; Espinoza J; Kimel S; Berns MW
J Photochem Photobiol B; 1999; 53(1-3):44-52. PubMed ID: 10672528
[TBL] [Abstract][Full Text] [Related]
16. [Photodynamic therapy with verteporfin for recurrent choroidal neovascularisation (CNV) following prior argon laser coagulation].
Gabel-Pfisterer A; Wehner A; Heimann H; Foerster MH; Wachtlin J
Ophthalmologe; 2005 Jun; 102(6):592-6. PubMed ID: 15662503
[TBL] [Abstract][Full Text] [Related]
17. Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model.
Debefve E; Pegaz B; van den Bergh H; Wagnières G; Lange N; Ballini JP
Angiogenesis; 2008; 11(3):235-43. PubMed ID: 18324477
[TBL] [Abstract][Full Text] [Related]
18. Simple, reliable and fast spectrofluorometric method for determination of plasma Verteporfin (Visudyne) levels during photodynamic therapy for choroidal neovascularization.
Aquaron R; Forzano O; Murati JL; Fayet G; Aquaron C; Ridings B
Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):925-30. PubMed ID: 12699252
[TBL] [Abstract][Full Text] [Related]
19. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy.
Chen B; Pogue BW; Hoopes PJ; Hasan T
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1216-26. PubMed ID: 15752904
[TBL] [Abstract][Full Text] [Related]
20. Blood flow dynamics after photodynamic therapy with verteporfin in the RIF-1 tumor.
Chen B; Pogue BW; Goodwin IA; O'Hara JA; Wilmot CM; Hutchins JE; Hoopes PJ; Hasan T
Radiat Res; 2003 Oct; 160(4):452-9. PubMed ID: 12968929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
